# US 2007/0104796 A1 · Use of xenon with hypothermia for treating neonatal asphyxia

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2007/0104796 A1
- Document ID: US20070104796A1
- Status: Published application
- Kind: A1
- Application number: 10/573,093
- Filed: 2004-10-11
- Published: 2007-05-10
- Earliest claimed: 2003-10-10
- Assignees: Protexeon Limited
- Inventors: Nicholas Franks; Mervyn Maze
- Web page: https://patentgrep.com/patent/US20070104796A1

## CPC

- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K 9/007: {Pulmonary tract; Aromatherapy}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to the use of xenon in the preparation of a medicament for the treatment of neonatal asphyxia in a neonatal subject, wherein said medicament is for use in combination with hypothermia.

## Claims

### Claim 1

Use of xenon in the preparation of a medicament for the treatment of neonatal asphyxia in a neonatal subject, wherein said medicament is for use in combination with hypothermia.

### Claim 2

(canceled)

### Claim 3

(canceled)

### Claim 4

(canceled)

### Claim 5

(canceled)

### Claim 6

(canceled)

### Claim 7

(canceled)

### Claim 8

(canceled)

### Claim 9

(canceled)

### Claim 10

(canceled)

### Claim 11

(canceled)

### Claim 12

(canceled)

### Claim 13

(canceled)

### Claim 14

(canceled)

### Claim 15

(canceled)

### Claim 16

(canceled)

### Claim 17

(canceled)

### Claim 18

(canceled)

### Claim 19

(canceled)

### Claim 20

A method of treating neonatal asphyxia in a mammal in need thereof, said method comprising:
(a) administering a therapeutically effective amount of xenon to the mammal; and
(b) subjecting the mammal to hypothermia.

### Claim 21 (depends on 20)

A method according to claim 20 wherein the mammal is a human.

### Claim 22 (depends on 20)

A method according to claim 20 wherein the xenon is administered in combination with a pharmaceutically acceptable carrier, diluent or excipient.

### Claim 23 (depends on 20)

A method according to claim 20 wherein the xenon is administered by inhalation.

### Claim 24 (depends on 23)

A method according to claim 23 wherein the xenon is administered in the form of a 20 to 70% v/v xenon/air mixture.

### Claim 25 (depends on 20)

A method according to claim 20 wherein the xenon is administered by perfusion.

### Claim 26 (depends on 20, 21, 22)

A method according to claim 20 to 22 wherein the xenon is administered in the form of a solution or emulsion.

### Claim 27 (depends on 26)

A method according to claim 26 wherein the xenon is administered in the form of a lipid emulsion.

### Claim 28 (depends on 26)

A method according to claim 26 wherein the xenon is administered intravenously, neuraxially or transdermally.

### Claim 29 (depends on 20)

A method according to claim 20 wherein the xenon is administered simultaneously, sequentially or separately with hypothermia.

### Claim 30 (depends on 29)

A method according to claim 29 wherein the xenon is administered simultaneously with hypothermia.

### Claim 31 (depends on 20)

A method according to claim 20 wherein the temperature of the mammal is maintained at a temperature of from about 32° C. to about 36° C.

### Claim 32 (depends on 31)

A method according to claim 31 wherein the temperature of the mammal is maintained at a temperature of from about 33° C. to about 35° C.

### Claim 33 (depends on 20)

A method according to claim 20 wherein the hypothermia is maintained for a period of at least 6 hours after the hypoxic-ischemic (HI) insult.

### Claim 34 (depends on 20)

A method according to claim 20 wherein the hypothermia is maintained for a period of from about 6 to about 24 hours after the hypoxic-ischemic (HI) insult.

### Claim 35 (depends on 20)

A method according to claim 20 wherein the xenon is administered to the mother of the mammal prior to birth.

### Claim 36 (depends on 35)

A method according to claim 35 wherein the xenon is administered to the mother of the mammal prior to, or during, labour.

### Claim 37 (depends on 35)

A method according to claim 35 wherein the xenon is administered to the mother of the mammal for up to about 24 hours prior to birth.

### Claim 38 (depends on 20)

A method according to claim 20 wherein the xenon is administered in a therapeutically effective amount.

### Claim 39 (depends on 20)

A method according to claim 20 wherein the xenon is administered in a sub-therapeutically effective amount.

### Claim 40 (depends on 20)

A method according to claim 20 wherein the xenon is administered in a combination with an aesthetic selected from isoflurane, sevoflurane and desflurane.

### Claim 41

A method of treating neonatal asphyxia in a mammal in need thereof, said method comprising administering a therapeutically effective amount of xenon to the mammal in combination with hypothermia.

### Claim 42

Use of xenon in the preparation of a medicament for the treatment of neonatal asphyxia, wherein said treatment comprises administering to a subject simultaneously, sequentially or separately xenon in combination with hypothermia.

### Claim 43

Use of xenon, in combination with hypothermia, for the treatment of neonatal asphyxia.

### Claim 44

A method of treating neonatal asphyxia in a mammal in need thereof, said method comprising:
(a) administering a therapeutically effective amount of xenon to the mother of the mammal prior to and/or during labour; and
(b) subjecting the mammal to hypothermia after birth.

### Claim 45

(canceled)
